CV

CVS Health CorpNYSE CVS Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

73.063

Mega

Exchange

XNYS - New York Stock Exchange, Inc

CVS Stock Analysis

CV

Avoid

Based on Eyestock quantitative analysis, CVS`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

6/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

5.5 %

Undervalued

Market cap $B

73.063

Dividend yield

4.41 %

Shares outstanding

1 284.11 B

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) solutions, including plan design offerings and administration, retail pharmacy network management services, mail order pharmacy, specialty pharmacy, clinical services, disease management services and medical spend management. Retail/LTC segment sells prescription drugs and a range of health and wellness products and general merchandise. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services. The firm's services include health & wellness services, health plans, pharmacy services and prescription drug coverage. The firm has approximately 9,000 retail locations, over 1,100 walk-in medical clinics, a pharmacy benefits manager.

View Section: Eyestock Rating